Back

High definition analyses of single cohort, whole genome sequencing data provides a direct route to defining sub-phenotypes and personalising medicine

Joyce, K. E.; Onabanjo, E.; Brownlow, S.; Nur, F.; Olupona, K.; Fakayode, K.; Sroya, M.; Thomas, G.; Ferguson, T.; Redhead, J.; Millar, C. M.; Cooper, N.; Layton, D. M.; Caulfield, M. J.; Boardman-Pretty, F.; Genomics England Research Consortium, ; Shovlin, C. L.

2021-09-01 genetic and genomic medicine
10.1101/2021.08.28.21262560 medRxiv
Show abstract

Possession of a clinical or molecular disease label alters the context in which life-course events operate, but rarely explains the phenotypic variability observed by clinicians. Whole genome sequencing of unselected endothelial vasculopathy patients demonstrated more than a third had rare, likely deleterious variants in clinically-relevant genes unrelated to their vasculopathy (1 in 10 within platelet genes; 1 in 8 within coagulation genes; and 1 in 4 within erythrocyte hemolytic genes). High erythrocyte membrane variant rates paralleled genomic damage and prevalence indices in the general population. In blinded analyses, patients with greater hemorrhagic severity that had been attributed solely to their vasculopathy had more deleterious variants in platelet (Spearman {rho}=0.25, p=0.008) and coagulation (Spearman {rho}=0.21, p=0.024) genes. We conclude that rare diseases can provide insights for medicine beyond their primary pathophysiology, and propose a framework based on rare variants to inform interpretative approaches to accelerate clinical impact from whole genome sequencing.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.